Search

Your search keyword '"Steger, G G"' showing total 188 results

Search Constraints

Start Over You searched for: Author "Steger, G G" Remove constraint Author: "Steger, G G"
188 results on '"Steger, G G"'

Search Results

3. Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

11. Abstract

22. Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors

23. Brain metastases free survival differs between breast cancer subtypes

24. Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases

28. Therapeutic management of metastatic breast cancer across Europe: European observatory and survey (EOS).

29. Systemic therapy and overall survival (OS) in patients (pts) with brain metastases from HER2-positive (HER2+) metastatic breast cancer (MBC).

30. Effect of change of body mass index (BMI) during therapy on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the ABCSG-12 trial.

32. Bevacizumab (Bev) combined with either capecitabine (X) or weekly paclitaxel (Pac) as first-line chemotherapy (CT) for HER2-negative, locally recurrent or metastatic breast cancer (LR/MBC): Preliminary safety data from the CECOG phase III TURANDOT trial.

36. Randomized, double-blind, placebo-controlled, phase III study of bevacizumab with docetaxel or docetaxel with placebo as first-line therapy for patients with locally recurrent or metastatic breast cancer (mBC): AVADO.

40. Randomized comparison of neoadjuvant docetaxel (D), epirubicin (E) and pegfilgrastim (P) (+ trastuzumab [T] in HER2+ patients [pts]) with and without capecitabine (C) for operable breast cancer (BC): Results of a planned safety analysis of ABCSG 24

Catalog

Books, media, physical & digital resources